- funded by IMI-JU
- 01 March 2011 - 31 August 2016
- 11 EFPIA members
- 10 Academia and 5 SME's
- Total cost € 23,032,609
Drug Combinations in Oncology, Rocchetti Tumor Growth Inhibition model
Predictive PK-PD modelling of tumor growth after administration of antiangiogenic and cytotoxic drugs, as single-agents and in combination therapy.
Model used (Rocchetti et al., Cancer Chemother Pharmacol 2013)
Material extracted from the DDMoRe face-to-face course “Model-informed drug development in Oncology (Advanced)”
Authors of the original exercise
Elisa Borella, Universita degli Studi di Pavia
Ricchardo Bagarotti, Universita degli Studi di Pavia
Niklas Hartung, Freie Universitaet Berlin
Charlotte Kloft, Freie Universitaet Berlin
Authors of the online training material
Niklas Hartung, Freie Universitaet Berlin
Charlotte Kloft, Freie Universitaet Berlin
© 2012 - 2016 | DDMoRe, all rights reserved. 
Support was received from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115156, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution. The DDMoRe project is also financially supported by contributions from Academic and SME partners